Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus

Taylor, 2009, Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report—2009, J Heart Lung Transplant, 28, 1007, 10.1016/j.healun.2009.08.014 Bertoni, 2003, Diabetes and idiopathic cardiomyopathy: a nationwide case-control study, Diabetes Care, 26, 2791, 10.2337/diacare.26.10.2791 Murarka, 2010, Diabetic cardiomyopathy, J Card Failure, 16, 971, 10.1016/j.cardfail.2010.07.249 Ernande, 2012, Diabetic cardiomyopathy, myth or reality?, Arch Cardiovasc Dis, 105, 218, 10.1016/j.acvd.2011.11.007 Gerli, 1986, Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy, Am Heart J, 112, 350, 10.1016/0002-8703(86)90274-7 Fu, 1993, Location of functional autoimmune epitope on muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy, J Clin Invest, 91, 1964, 10.1172/JCI116416 Magnusson, 1994, Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta-1-adrenoceptor with positive chronotropic effect, Circulation, 89, 2760, 10.1161/01.CIR.89.6.2760 Wallukat, 1995, Anti-β1-adrenoceptor antibodies with chronotropic activity from serum of patients with dilated cardio-myopathy: mapping of epitopes in the first and second extracellular loops, J Mol Cell Cardiol, 27, 397, 10.1016/S0022-2828(08)80036-3 Müller, 1997, Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy, Circulation, 96, 542, 10.1161/01.CIR.96.2.542 Jahns, 1999, Autoantibodies activating human beta adrenergic receptors are associated with reduced cardiac function in chronic heart failure, Circulation, 99, 649, 10.1161/01.CIR.99.5.649 Dandel, 2012, Role of β1-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy, Immunobiology, 217, 511, 10.1016/j.imbio.2011.07.012 Jahns, 2004, Direct evidence for beta-1 adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy, J Clin Invest, 113, 1419, 10.1172/JCI200420149 Dandel, 2012, Long-term benefits of immunoadsorption in beta-1 adrenoreceptor autoantibody positive transplant candidates with dilated cardiomyopathy, Eur J Heart Fail, 14, 1374, 10.1093/eurjhf/hfs123 Wallukat, 1996, Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption, Int J Cardiol, 54, 91, 10.1016/0167-5273(96)02598-3 Dörfel, 1997, Short term hemodynamic effects of immunoadsorption in dilated cardiomyopathy, Circulation, 95, 1994, 10.1161/01.CIR.95.8.1994 Felix, 2000, Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized study, J Am Coll Cardiol, 35, 1590, 10.1016/S0735-1097(00)00568-4 Mobini, 2003, Hemodynamic improvement and removal of autoantibodies aganst beta-1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy, J Autoimmun, 20, 345, 10.1016/S0896-8411(03)00042-8 Herda, 2010, Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy, Am Heart J, 159, 809, 10.1016/j.ahj.2010.01.012 Staudt, 2006, Immunoadsorption in dilated cardiomyopathy: 6 months results from a randomized study, Am Heart J, 152, 10.1016/j.ahj.2006.06.027 Dandel, 2013, Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension, Atherosclerosis Suppl, 14, 203, 10.1016/j.atherosclerosissup.2012.10.029 Schwartz, 2013, Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue, J Clin Apheresis, 28, 145, 10.1002/jca.21276 Hempel, 2009, Sera from patients with type 2 diabetes contain agonistic antibodies against G protein-couplet receptors, Scand J Immunol, 70, 159, 10.1111/j.1365-3083.2009.02280.x Zhao, 2010, Positive rate of auto-antibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension, Zhonghua Xin Xue Guan Bing Za Zhi, 38, 139 Ryden, 2013, Eur Heart J, 34, 3035, 10.1093/eurheartj/eht108 McGuire, 2012, Diabetes and the cardiovascular system, 1392 Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 Litwin, 2013, Diabetes and the heart: is there objective evidence of human diabetic cardiomyopathy?, Diabetes, 62, 3329, 10.2337/db13-0683